Articles tagged with Immune Disorders
A Rutgers Health-led study found that Medicaid expansion increased PrEP prescriptions overall, but racial disparities in access persisted. White Americans received the most PrEP prescriptions (94%), while Black and Hispanic communities were underrepresented, with 13% and 24% respectively.
A 47-year-old man from New Jersey died after consuming beef due to a tick-borne meat allergy caused by the Lone Star tick's alpha-gal sugar. Researchers identified the allergy and its link to fatal anaphylaxis, urging physicians to investigate severe abdominal pain after eating red meat in areas with high Lone Star tick populations.
Autoimmune hepatitis is often associated with other autoimmune conditions, including thyroid disease, type 1 diabetes, inflammatory bowel disease, and rheumatologic disorders. The study highlights the need for precise diagnostic criteria and interdisciplinary management strategies to optimize outcomes in patients with multi-organ autoi...
Scientists have discovered that immune cells shed their glycocalyx layer to move into tissues, changing the understanding of inflammatory skin diseases like psoriasis. This finding may lead to new approaches in developing drugs targeting immune cell movement and treating infections and inflammatory diseases.
A University of Houston researcher identifies a protein that may reduce high ketone levels in diabetic patients, potentially improving health outcomes. The study also shows that the protein promotes muscle ketolysis and running capacity in mice.
Pennington Biomedical researchers will participate in numerous panels and presentations during the conference, sharing their latest findings on obesity treatment and prevention. The institution is well-represented at the event, with faculty members among the experts leading courses, presentations, and speaker panels.
Salk Institute researchers have determined the structure of HIV's integrase protein during its newly discovered function, enabling the development of better HIV therapeutics. The study reveals a surprising flexibility in the protein's architecture, which can interact with both DNA and RNA, paving the way for new integrase-targeting drugs.
Researchers have identified 57 unique proteins in urine that can indicate active damage to the kidneys, enabling non-invasive monitoring of lupus nephritis. This breakthrough could transform diagnosis and treatment for millions worldwide affected by systemic lupus erythematosus.
The US needs a new strategy for insurance coverage and access to cell and gene therapies due to high up-front costs. In contrast, Europe has approved 19 CGTs with most being reimbursed within two years of approval based on demonstrated added therapeutic value.
A new lab-designed protein has been discovered to regulate blood glucose levels, offering a potential new treatment avenue for people with Type 1 diabetes. The substance combines insulin and glucagon into one molecule, signaling the liver to respond naturally.
A study led by Julie Pilitsis, MD, PhD, found a possible connection between chronic pain and eosinophilia, a white blood cell condition, in patients undergoing spinal cord stimulation or implanted pain medicine pumps. The study suggests that eosinophilia may be an immune biomarker for chronic pain.
A new study found that breastfeeding until six months of age helps babies fight off infections and reduce chronic inflammation. The researchers identified specific lipids in breast milk, such as plasmalogens, which appear to lower inflammation and improve immune health.
A newly identified antibody, 04_A06, has been found to block 98.5% of over 300 different HIV strains in laboratory tests. In humanized mice models, the antibody reduced viral load to undetectable levels, offering a promising approach for HIV prevention and treatment.
A new survey found that 72% of respondents agree that plasma-derived medicines can save lives, but most haven't donated. Plasma is essential in producing treatments for various serious health conditions.
Researchers at La Jolla Institute for Immunology discovered that ALS is likely caused by an autoimmune reaction triggered by inflammatory CD4+ T cells targeting specific proteins in the nervous system. Anti-inflammatory CD4+ T cells may slow disease progression and prolong survival times.
Researchers discovered widespread inflammation, immune cell dysfunction, and cellular reprogramming in people at risk for RA. The study identified new biologic targets for prevention and ways to improve treatments.
A study in mice found that maternal consumption of emulsifiers can alter the gut microbiota of their offspring, leading to increased risk of chronic inflammatory gut disorders and obesity. The research highlights the importance of regulating food additives, particularly in powdered baby formulas, to prevent long-term health consequences.
A study by the CNRS-led research team highlights the key role of Tat, a viral protein that blocks autophagy, promoting Mycobacterium tuberculosis survival and multiplication. Restoring autophagy mechanism could lead to innovative therapeutic strategies for better protection against tuberculosis in HIV-positive patients.
Researchers from the Stowers Institute for Medical Research have identified a common process that powers the creation of protein formations that assemble like a 3D puzzle, triggering inflammation and cell death. This 'Catch-22' mechanism may be one of the fundamental reasons why we age.
A new study from the University of Birmingham has found that immune ageing may be a driver of rheumatoid arthritis rather than a consequence of the disease. The research detected features of immune system ageing in the earliest stages of RA, even before clinical diagnosis, suggesting that early intervention is possible.
Researchers mapped the surface envelope glycoprotein of human endogenous retroviruses, opening doors to new diagnostic and therapeutic opportunities. The study revealed specific antibodies that target the viral proteins, potentially leading to new cancer immunotherapies and treatments for autoimmune diseases.
Scientists have created a detailed map of cell behavior in the small intestine of people with coeliac disease using single-cell RNA sequencing. The study found that immune signals from immune system proteins encourage fibroblasts to support changes in the gut lining, suggesting communication between cells plays a key role in the disease.
Scientists have developed a monoclonal antibody to combat life-threatening inflammatory diseases like sepsis and ARDS. The antibody shows promise in blocking the immune system's hyperactive response and restoring healthy function without unwanted side effects.
The Mount Sinai Hospital has launched the country's first clinical manual for treating infection-associated chronic illnesses (IACIs), a comprehensive guide for diagnosis and care. The manual covers extensive learnings from the Cohen Center and provides practical strategies for clinicians to support patients with conditions such as lon...
Researchers found that neutralizing the TSLP protein significantly improves Eosinophilic Esophagitis symptoms, suggesting a potential new treatment strategy. The study's findings may also have implications for other allergic disorders.
Researchers at Cornell University developed an implant system that can treat Type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, enabling long-term treatment for chronic diseases. The system could also potentially provide treatment for other autoimmune diseases.
Researchers found that children unexposed to HIV had higher taxonomic turnover in their oral microbiomes, indicating less adaptability to environmental changes. Children living with HIV had more stable oral microbiomes and higher frequencies of cavity-causing bacteria.
Researchers at La Jolla Institute for Immunology examine how genetics, sex hormones, and environmental factors shape the immune system. Women have a stronger immune response due to their XX chromosomes and estrogen, but also face an increased risk of autoimmune diseases.
Researchers discovered that our bodies add sugars to RNA, shielding it from the immune system. This 'sugarcoating' prevents inflammation and helps clean up dead cells.
A new study shows that delivering a single injection of gene therapy at birth may offer years-long protection against HIV. The treatment uses an adeno-associated virus to deliver instructions to muscle cells, which produce broadly neutralizing antibodies capable of neutralizing multiple strains of HIV.
Research reveals that prenatal PFAS exposure can alter infants' developing immune systems, leading to lasting imprints on their ability to fight disease. Exposure to low levels of PFAS was associated with changes in key T-cell populations, including T follicular helper cells and regulatory T cells.
Research warns that GLP-1 drugs may not provide the long-term health benefit of improved heart and lung function. While they help with weight loss, patients may experience significant muscle loss, which can increase cardiovascular disease risk. Doctors are urging additional research to better understand the effects of these drugs.
A study published in PLOS One found a clear link between low vitamin D levels and an increased risk of being hospitalized by COVID-19. However, no association was found between low vitamin D and the risk of catching COVID-19.
A team of researchers at KAIST has identified a specialized gut-brain pathway for glucose sensing, which plays a central role in maintaining energy balance and metabolic homeostasis. This discovery opens up new therapeutic possibilities for metabolic diseases.
Research reveals a direct connection between diabetic peripheral neuropathy and skeletal health, linking nerve damage to reduced cell signaling. The study shows that diabetic mice with nerve damage had weakened bones due to impaired nerve-bone communication.
Researchers successfully modulate the activity of key immune system genes using CRISPR-Cas9 technology, revealing a new approach to treating inflammatory diseases. The study demonstrates precise control over gene expression and its impact on tumour growth and inflammation.
Researchers at MIT developed an implantable device that can store glucagon to counteract hypoglycemia, a life-threatening condition for people with Type 1 diabetes. The device, about the size of a quarter, contains a small reservoir made of 3D-printed polymer and can be triggered remotely or automatically by a sensor.
A Cornell University study found that people with more copies of the AMY1 gene have higher salivary amylase activity, which may be protective against Type 2 diabetes. Researchers suggest that a higher copy number may lead to earlier insulin release and lower blood glucose levels.
A groundbreaking study has uncovered the unique architecture of cells and signals inside the joint as inflammation takes hold in children with arthritis. The research provides a new way forward for understanding this condition, which affects over 10,000 children in the UK.
Researchers investigated the link between HIV treatment regimens and osteoarthritis development, revealing that certain medications like lopinavir can exacerbate OA in the knee. The study's findings have important implications for people living with HIV, highlighting the need to carefully consider treatment options.
A new UVA Health study finds that stocking two twin packs of epinephrine autoinjectors and having campers leave their own at home is the most cost-effective strategy for residential camps. This approach comes with an estimated overall cost of $4.33 per camper.
Research found that macrophages use two independent pathways to regulate inflammatory and lysosomal responses to toxic particles. The study identified key transcription factors and signaling pathways involved, offering potential therapeutic opportunities to quell inflammation.
Researchers developed a new laboratory method that helps diagnose patients with suspected immune system disorders like activated-PI3Kδ syndrome (APDS). The method identified dozens of additional genetic variations associated with the condition, enabling rapid diagnosis and treatment. This breakthrough may also help identify more patien...
Research highlights the significant consequences of diagnostic delays for lupus patients, who often experience multiple misdiagnoses before receiving an accurate diagnosis. The study found that 'diagnostic overshadowing' is a major cause of these delays, leading to irreparable organ damage and poor quality of life.
Researchers at La Jolla Institute for Immunology discovered that T cell reactivity is highest during the prodromal period in Parkinson's disease, which can last for decades before noticeable symptoms. This finding may guide the development of early diagnostic tools and provide a new timeline for Parkinson's disease detection.
The small intestine's epithelial cells and immune cells work together to maintain gut integrity and regulate immune responses. Dysfunction in these cellular networks is linked to systemic diseases such as obesity, insulin resistance, and autoimmune conditions.
Research suggests that interacting with dogs can modify a child's risk of developing atopic eczema, potentially due to the impact on immune cells. The findings provide new insights into the complex relationship between genetics and environment in the development of eczema.
Researchers at University of Virginia Health System discovered that an immune molecule called STING drives the formation of harmful plaques and protein tangles associated with Alzheimer's. Blocking STING protected lab mice from mental decline, suggesting a promising treatment target for neurodegenerative diseases.
Researchers have uncovered a key reason why HIV remains difficult to cure, revealing that subtle variations in the Rev-RRE axis influence viral replication and latency reactivation. Understanding this regulatory system could help develop strategies to flush out the dormant virus and eliminate it for good.
Researchers at the Weizmann Institute of Science have discovered a coordinated network of four cell types crucial for preventing immune reactions to food. This network is initiated by ROR-gamma-t cells, which temporarily suspend tolerance mechanisms to combat infection, and then resume when the threat has passed.
Researchers at La Jolla Institute for Immunology discovered that CD4+ T cells target Chikungunya virus, leading to chronic inflammation and joint pain. The study suggests that these monofunctional T cells may be the culprits behind arthritis-like symptoms in CHIKV patients.
Researchers discovered that certain immune cells in the gut of refractory coeliac disease patients carry genetic mutations, driving ongoing intestinal inflammation and symptoms. The study's findings suggest a new way to diagnose and potentially treat the most severe form of coeliac disease.
The RSV protein subunit vaccine showed similar efficacy to clinical trials, with diminished immune response in immunocompromised patients. The vaccine was associated with a small increased risk of Guillain-Barré syndrome, but not immune thrombocytopenic purpura.
A new approach targeting inflammation may help prevent or slow the progression of Type 1 diabetes by blocking TYK2 protein signaling. Researchers found that inhibiting this protein reduced harmful inflammation in the pancreas and protected insulin-producing beta cells.
A new study found that women with the most common autoimmune diseases die from cardiovascular disease more frequently than men. This highlights the need for improved CVD risk management in these patients.
Scientists have identified a key component in launching immune activity and overactivity, providing a potential target for therapies that could prevent debilitating illnesses. The researchers discovered a protein in cells that spurs the release of infection-fighting molecules, which is essential for controlling the disease.
Tracheobronchial involvement in relapsing polychondritis requires a multimodal approach for diagnosis and treatment. Key findings include the use of dynamic thoracic imaging and flexible bronchoscopy to assess lesions, as well as the development of immunosuppressant therapies such as TNF-α inhibitors to improve prognosis.
Enodia Therapeutics, launched by Institut Pasteur and Argobio, leverages AI to develop selective inhibitors of the Sec61/translocon molecular complex for treating cancer, inflammatory diseases, and viral infections. The company's breakthrough technology has earned a prestigious Golden Ticket Award from Pfizer.
A new sponge-like implant helps guide a treatment that slows or stops a degenerative condition similar to multiple sclerosis. The implant attracted diseased immune cells, enabling researchers to study and target them with a nanoparticle-based treatment, which prevented mice from developing symptoms such as paralysis if administered early.
Researchers from Aarhus University have developed a method to track disease progression in patients with autoimmune diseases. The new method identifies large immuno-active complexes and can be measured in parallel, increasing capacity and reducing the need for training new staff or investing in equipment.